Business
‘Not of use for much’: Hospitals told not to give remdesivir to COVID-19 patients – Sydney Morning Herald
The medication was one of the drugs used to treat US President Donald Trump’s coronavirus infection.
The antiviral, known by the brand name Veklury, is one of only two medicines currently authorised to treat COVID-19 patients across the world. But a large WHO-led test known as the Solidarity Trial showed last month that it had little or no effect on 28-day mortality or length of hospital stays for COVID-19 patients.
The medication was one of the drugs used to treat US President Donald Trump’s coronavirus infection, and had been shown in previous studies to have cut time to recovery. It is authorised…
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News14 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now